Physician profile
Matthew Harrison Martell
NPI 1104269463
$48,369.90
in general payments reported to CMS, 2019-2025
11 companies · $43K in 2025
The $43K reported for 2025 was more than what 91% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $214 · 2021: $1,459 · 2022: $2,086 · 2023: $810 · 2024: $710 · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $42K · Food and Beverage: $2,454 · Consulting Fee: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $41,555.25 |
| Food and Beverage | $2,454.36 |
| Consulting Fee | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $41,555.25 | 2025 | Amnioexcel Plus, Amnioexcel, Micromatrix |
| Smith+Nephew, INC. | $3,045.31 | 2019-2025 | Trigen Meta-Nail, Evos, Trigen Intertan |
| Medical Device Business Services, INC. | $1,752.59 | 2022 | |
| Depuy Synthes Sales INC. | $1,141.90 | 2020-2025 | Na, Va-Lcp, Tfn-Advance |
| Bone Support INC. | $250.00 | 2023 | Ceramentbone Void Filler |
| Stryker Corporation | $166.40 | 2024 | T2 |
| Flower Orthopedics Coporation | $140.00 | 2025 | |
| Skeletal Dynamics INC | $134.61 | 2021-2023 | Ijs, Geminus, Align |
| United Orthopedics LLC | $110.38 | 2025 | |
| Medline Industries Lp | $59.41 | 2023 | |
| Ebi, LLC | $14.05 | 2025 | Biomet Ebi Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Martell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.